INT252951

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.17
First Reported 2008
Last Reported 2010
Negated 0
Speculated 2
Reported most in Body
Documents 2
Total Number 5
Disease Relevance 1.53
Pain Relevance 0.23

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

pigmentation (Oca2) cell proliferation (Oca2) transport (Oca2)
transmembrane transport (Oca2)
Anatomy Link Frequency
GH3 2
ligament 1
Oca2 (Mus musculus)
Pain Link Frequency Relevance Heat
imagery 2 87.60 High High
Eae 2 63.40 Quite High
Pain 5 56.56 Quite High
Dismenorea 6 53.44 Quite High
Piles 4 40.64 Quite Low
Central nervous system 3 34.40 Quite Low
metalloproteinase 18 5.00 Very Low Very Low Very Low
cytokine 4 5.00 Very Low Very Low Very Low
tolerance 4 5.00 Very Low Very Low Very Low
Inflammation 3 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Ovarian Cancer 32 100.00 Very High Very High Very High
Pituitary Cancer 26 100.00 Very High Very High Very High
Prolapse 52 81.04 Quite High
Wound Infection 2 75.76 Quite High
Postoperative Complications 4 72.88 Quite High
Hemorrhage 12 69.76 Quite High
Infection 33 66.08 Quite High
Overactive Bladder 6 62.08 Quite High
Encephalitis 15 59.60 Quite High
Fistula 2 59.12 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
In a randomized controlled trial, the objective success rate of P-IVS was 95%, which was comparable to that of sacrospinous ligament fixation [11].
Localization (rate) of P-IVS in ligament
1) Confidence 0.17 Published 2010 Journal Korean Journal of Urology Section Body Doc Link PMC2855447 Disease Relevance 0.56 Pain Relevance 0.03
Compared with the recently released Prolift system (Ethicon Women's Health and Urology, Somerville, USA), the mean mesh-related complication rate of P-IVS was lower, presumably because of the smaller amount of mesh used [23].
Localization (rate) of P-IVS
2) Confidence 0.17 Published 2010 Journal Korean Journal of Urology Section Body Doc Link PMC2855447 Disease Relevance 0.34 Pain Relevance 0.11
Transfected cells were observed under florescent microscope periodically to check the expression of green fluorescent protein (GFP) fused CHPV P protein and confirmed by western blotting using anti-GFP antibodies (Invitrogen, Carlsbad, CA, USA).


Localization (fused) of P protein
3) Confidence 0.07 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2797643 Disease Relevance 0.24 Pain Relevance 0
These investigators also reported the nuclear localization of PTTG1-EGFP in other cell lines like NIH3T3, rat GH3, mouse AtT20 pituitary tumor, SKOV-3 human OCA, and COS-7 monkey kidney cells.
Spec (investigators) Localization (localization) of OCA in GH3 associated with ovarian cancer and pituitary cancer
4) Confidence 0.02 Published 2008 Journal J Ovarian Res Section Body Doc Link PMC2584053 Disease Relevance 0.20 Pain Relevance 0.04
These investigators also reported the nuclear localization of PTTG1-EGFP in other cell lines like NIH3T3, rat GH3, mouse AtT20 pituitary tumor, SKOV-3 human OCA, and COS-7 monkey kidney cells.
Spec (investigators) Localization (localization) of OCA in GH3 associated with ovarian cancer and pituitary cancer
5) Confidence 0.02 Published 2008 Journal J Ovarian Res Section Body Doc Link PMC2584053 Disease Relevance 0.20 Pain Relevance 0.04

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox